Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Resilience to autosomal dominant Alzheimer’s disease in a Reelin-COLBOS heterozygous man
Francisco Lopera, Claudia Mariño, Anita Chandrahas, et al.
Nature Medicine (2023) Vol. 29, Iss. 5, pp. 1243-1252
Open Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

2024 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3708-3821
Open Access | Times Cited: 544
Accelerating Alzheimer’s therapeutic development: The past and future of clinical trials
Adam L. Boxer, Reisa A. Sperling
Cell (2023) Vol. 186, Iss. 22, pp. 4757-4772
Open Access | Times Cited: 72
Is Alzheimer disease a disease?
Amos D. Korczyn, Lea T. Grinberg
Nature Reviews Neurology (2024) Vol. 20, Iss. 4, pp. 245-251
Closed Access | Times Cited: 60
Single-cell multiregion dissection of Alzheimer’s disease
Hansruedi Mathys, Carles A. Boix, Leyla Anne Akay, et al.
Nature (2024) Vol. 632, Iss. 8026, pp. 858-868
Open Access | Times Cited: 56
Molecular and cellular mechanisms of selective vulnerability in neurodegenerative diseases
Martin Kampmann
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 5, pp. 351-371
Closed Access | Times Cited: 34
Lessons Learned from Approval of Aducanumab for Alzheimer's Disease
Judith L. Heidebrink, Henry L. Paulson
Annual Review of Medicine (2024) Vol. 75, Iss. 1, pp. 99-111
Open Access | Times Cited: 21
The concept of resilience to Alzheimer’s Disease: current definitions and cellular and molecular mechanisms
Luuk E. de Vries, Inge Huitinga, Helmut W. Kessels, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 21
Entorhinal‐based path integration selectively predicts midlife risk of Alzheimer's disease
Coco Newton, Marianna Pope, Catarina Rua, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 4, pp. 2779-2793
Open Access | Times Cited: 20
Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy
Qiuyang Zheng, Xin Wang
Protein & Cell (2024)
Open Access | Times Cited: 19
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial
Hayley R. C. Shanks, Kewei Chen, Eric M. Reiman, et al.
Nature Medicine (2024) Vol. 30, Iss. 6, pp. 1761-1770
Open Access | Times Cited: 17
Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementia
Jorge J. Llibre‐Guerra, María Victoria Fernández, Nelly Joseph‐Mathurin, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 3
The 2022 symposium on dementia and brain aging in low‐ and middle‐income countries: Highlights on research, diagnosis, care, and impact
Raj N. Kalaria, Gladys E. Maestre, Simin Mahinrad, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 6, pp. 4290-4314
Open Access | Times Cited: 15
The Single Toxin Origin of Alzheimer’s Disease and Other Neurodegenerative Disorders Enables Targeted Approach to Treatment and Prevention
Martin Tolar, John A. Hey, Aidan Power, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2727-2727
Open Access | Times Cited: 9
APOE3 Christchurch modulates β-catenin/Wnt signaling in iPS cell-derived cerebral organoids from Alzheimer’s cases
Paula Perez‐Corredor, Timothy E. Vanderleest, Guido N. Vacano, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 9
Blood-brain barrier biomarkers
Juan F. Zapata-Acevedo, Alejandra Mantilla-Galindo, Karina Vargas-Sánchez, et al.
Advances in clinical chemistry (2024), pp. 1-88
Closed Access | Times Cited: 9
Harnessing myelin water fraction as an imaging biomarker of human cerebral aging, neurodegenerative diseases, and risk factors influencing myelination: A review
Mary E Faulkner, Zhaoyuan Gong, Alex Guo, et al.
Journal of Neurochemistry (2024)
Open Access | Times Cited: 8
Regulatory mechanism of Reelin activity: a platform for exploiting Reelin as a therapeutic agent
Mitsuharu Hattori
Frontiers in Molecular Neuroscience (2025) Vol. 18
Open Access | Times Cited: 1
Synapse vulnerability and resilience underlying Alzheimer’s disease
Raquel N. Taddei, Karen Duff
EBioMedicine (2025) Vol. 112, pp. 105557-105557
Open Access | Times Cited: 1
The impact of rare genetic variants on Alzheimer disease
Lara De Deyn, Kristel Sleegers
Nature Reviews Neurology (2025)
Closed Access | Times Cited: 1
Driving research on successful aging and neuroprotection in Latin America: Insights from the inaugural symposium on brain resilience and healthy longevity
Yakeel T. Quiroz, David Aguillón, Joseph F. Arboleda‐Velásquez, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access | Times Cited: 1
Reelin Signaling in Neurodevelopmental Disorders and Neurodegenerative Diseases
Aurélie Joly‐Amado, Neel Kulkarni, Kevin Nash
Brain Sciences (2023) Vol. 13, Iss. 10, pp. 1479-1479
Open Access | Times Cited: 19
Alzheimer’s Disease Treatment: The Search for a Breakthrough
Allison B. Reiss, Dalia Muhieddine, Berlin Jacob, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1084-1084
Open Access | Times Cited: 16
Alzheimer’s genes in microglia: a risk worth investigating
Ari Sudwarts, Gopal Thinakaran
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 16
Reelin links Apolipoprotein E4, Tau, and Amyloid‐β in Alzheimer’s disease
Ling Yi, Li Zeng, Qing Wang, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102339-102339
Closed Access | Times Cited: 7
Integrating amyloid and tau imaging with proteomics and genomics in Alzheimer’s disease
Gabriele Vilkaite, Jacob W. Vogel, Niklas Mattsson
Cell Reports Medicine (2024) Vol. 5, Iss. 9, pp. 101735-101735
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top